Birdwatch Note Rating
2023-05-20 23:49:33 UTC - HELPFUL
Rated by Participant: 3204257E89B79D0E7CF0873985227F9A51A117D178D50F9A13A2FC37915E6715
Participant Details
Original Note:
A phase three trial found Pfizer’s shot was nearly 82% effective at preventing severe disease from RSV in newborns during the first 90 days of life. RSV is a leading cause of hospitalization in children <1 year of age. https://pubmed.ncbi.nlm.nih.gov/23878043/ https://www.pfizer.com/news/press-release/press-release-detail/pfizer-announces-positive-top-line-data-phase-3-global
All Note Details